IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert DeHaven who wrote (138)	10/21/1997 6:16:00 PM
From: Chris Wilkinson	Read Replies (2) of 1510

Interim data collection point late in 1997 is the only official word I have seen. I believe the trial is scheduled to last 18 months. It is my hope that results will indicate that it would be inhumane to the control (placebo) group to continue the trial and IMNR will seek early approval of Remune. The next two months should be interesting. Don't forget we are in phase 2 for the arthritis therapy which looks very promising. Chris

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next